TCS Ranked Among Top 4 Life Sciences Service Providers by HFS Research
Tata Consultancy Services Ranked #3 in Overall Execution and OneOffice Alignment, and #4 for
Overall Innovation
Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS) has been ranked number four in the HFS Top 10 for Life Sciences Service Providers[1].
The report ranked TCS third for Overall Execution – number two for Scale of its Life Sciences Business, number three for Breath and Depth of offerings. TCS ranked fourth for Overall Innovation – number one in Life Sciences Technology Innovation, number three for Co-innovation and Collaboration and for Outcomes Realized. TCS was also placed third for OneOffice alignment.
“TCS helps leading life sciences companies across the world embrace next-gen technologies to innovate, accelerate their digital transformation journey, improve experiences, and drive growth,” said Vikas Jain, Co-Head, Life Sciences, TCS. “This ranking is a reflection of our sustained innovation, strong execution and thought leadership, that help TCS deliver superior business outcomes for customers.”
TCS partners with leading pharmaceutical and biotechnology companies to enable their digital transformation journey. TCS provides a full set of advisory and services and solutions including data and analytics, predictive and prescriptive analytics, advanced cloud-based platform solutions, genomics research, cognitive search, and digital labs.
The company’s extensive portfolio of intellectual property helps customers achieve better speed to market and superior business outcomes. TCS’ Cognitive Commercial Intelligence platform provides transformational and flexible analytics solutions to aid in marketing, sales excellence, pricing, market access, and real-world evidence. Its user-friendly Connected Clinical Trials platform offers advanced solutions such as digital patient and site engagement, intelligent medication, virtual and remote trials.
The TCS ADD platform helps clients transform the entire clinical R&D value chain and makes clinical trials more agile and safe. Powered by a cognitive artificial intelligence engine, data-driven smart analytics and IoT, it drives superior business outcome such as optimized and safer operations.
TCS’ Innovation Labs and its Co-Innovation Network provide an ideal environment for research in cutting-edge technologies across domains. TCS has also set up a Thought Leadership Institute, covering key technology areas such as analytics and insights, IoT, automation, and cloud, giving emerging businesses exposure to the best thinking across academia, industry analysts, and thinkers.
“TCS’ go-to-market is formed through their expertise across every element of the value chain augmented with an ecosystem approach. The pandemic energized the development of timely solutions like decentralized clinical trials, digital manufacturing, and connected labs amongst others. Their R&D capabilities include both dry and wet labs giving them critical advantages in terms of their growth options. All of these have helped them grow above the market for the last several years,” said Rohan Kulkarni, Vice President & Practice Leader, Healthcare Research, HFS.
“Our investments in innovation, certified talent pool, and comprehensive portfolio of intellectual property, make us the preferred transformation partner to our customers in the life sciences industry,” added Vikas Jain.
